Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily With Emtricitabine and Tenofovir Disoproxil Fumarate for Previously Untreated HIV1 Infection Week 96 Results From ONCEMRK a Randomized DoubleBlind Noninferiority Trial

Pedro CahnPaul E SaxKathleen SquiresJean-Michel MolinaMohammed RassoolE et al2023-04-132023-04-13ISI1525-4135https://hdl.handle.net/10539/35040Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily With Emtricitabine and Tenofovir Disoproxil Fumarate for Previously Untreated HIV1 Infection Week 96 Results From ONCEMRK a Randomized DoubleBlind Noninferiority Trial